×According to a study released on Wednesday, a single-injection antiviral treatment for newly infected COVID-19 patients lowered the likelihood of hospitalization by half in a large-scale clinical trial. The new medicine "showed remarkable benefits for both vaccinated and unvaccinated persons equally," according to Stanford University professor Jeffrey Glenn, co-author of the study published in the New England Journal of Medicine (NEJ....

Source: News 24 February 11, 2023 06:49 UTC